Article ID Journal Published Year Pages File Type
1224181 Journal of Pharmaceutical and Biomedical Analysis 2007 10 Pages PDF
Abstract

The tetrapyrrolic compound chlorin e6 is currently used as a pharmaceutical substance for Photolon formulation, which is utilized in photodynamic therapy of various diseases. It was found that chlorin e6 could contain both process- and degradation-related impurities. In order to understand their origin, the most abundant impurities were prepared by liquid extraction, preparative chromatography or chemical synthesis. By means of HPLC-PDA–MS, 1D and 2D NMR spectroscopy, these impurities were identified as chlorin e6 174-ethyl ester, chlorin e4, 15-hydroxyphyllochlorin, rhodochlorin, 151-hydroxymethylrhodochlorin δ-lactone, rhodochlorin-15-oxymethyl δ-lactone, rhodochlorin-15-oxymethyl δ-lactone 174-ethyl ester, 151-hydroxymethylrhodoporphyrin δ-lactone, rhodoporphyrin-15-oxymethyl δ-lactone and purpurin 18. The possible routes of formation of the chlorin derivatives upon the production and storage of chlorin e6 are discussed.

Related Topics
Physical Sciences and Engineering Chemistry Analytical Chemistry
Authors
, , ,